Lack of Association between Maternal Antibody and Protection of African Infants from Malaria Infection
Open Access
- 1 October 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (10), 5856-5863
- https://doi.org/10.1128/iai.68.10.5856-5863.2000
Abstract
Maternally derived antibodies are believed to protect infants against infection, but there is little direct evidence for a protective role of passively acquired antibodies against malaria. A longitudinal study of malaria infection in 143 infants was conducted in a region of southern Ghana where Plasmodium falciparum is endemic. Infants born in the high-transmission season were less likely to become infected in the first 20 weeks of life than children born in the low-transmission season. Plasma, obtained at birth, was tested for immunoglobulin G (IgG) and IgG subclasses to P. falciparum schizonts and recombinant circumsporozoite antigen, MSP-1 19 , MSP-2, AMA-1, and Pf155 (also called ring-infected erytrocyte surface antigen). Antibody levels at birth were not associated with resistance to malaria infection. On the contrary, antibodies at birth were positively associated with infection, indicating that high levels of maternally derived antibodies represent a marker for intensity of exposure to malaria infection in infants. However, all five children who experienced high-density infections (>100 parasites/μl of blood) were seronegative for MSP-1 19 at the time of infection.Keywords
This publication has 30 references indexed in Scilit:
- Maintaining the Immunological Balance in Parasitic Infections: A Role for TGF-β?Parasitology Today, 2000
- Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation ratesParasite Immunology, 1999
- Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmissionTropical Medicine & International Health, 1996
- Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-lThe Journal of Infectious Diseases, 1996
- The collectins in innate immunityCurrent Opinion in Immunology, 1996
- Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malariaParasite Immunology, 1995
- Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded proteinMolecular and Biochemical Parasitology, 1994
- Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of West AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparumJournal of Molecular Biology, 1987
- Milk Diet, p-Aminobenzoic Acid, and Malaria (P. Berghei)BMJ, 1953